Abstract:Treatment of high grade gliomas (HGGs) has remained elusive due to their high heterogeneity and aggressiveness. Surgery followed by radiotherapy represents the mainstay of treatment for HGG. However, the unfavorable location of the tumor that usually limits total resection and the resistance to radiation therapy are the major therapeutic problems. Chemotherapy with DNA alkylating agent temozolomide is also used to treat HGG, despite modest effects on survival. Disregulation of several growth factor receptors (GFRs) were detected in HGG and receptor amplification in glioblastoma has been suggested to be responsible for heterogeneity propagation through clonal evolution. Molecularly targeted agents inhibiting these membrane proteins have demonstrated significant cytotoxicity in several types of cancer cells when tested in preclinical models. Platelet-derived growth factor receptors (PDGFRs) and associated signaling were found to be implicated in gliomagenesis, moreover, HGG commonly display a Platelet-derived growth factor (PDGF) autocrine pathway that is not present in normal brain tissues. We have previously shown that both the susceptibility towards PDGFR and the impact of the PDGFR inactivation on the radiation response were different in different HGG cell lines. Therefore, we decided to extend our investigation, using two other HGG cell lines that express PDGFR at the cell surface. Here, we investigated the effect of PDGFR inhibition alone or in combination with gamma radiation in 11 and 15 HGG cell lines. Our results showed that while targeting the PDGFR represents a good means of treatment in HGG, the combination of receptor inhibition with gamma radiation did not result in any discernable difference compared to the single treatment. The PI3K/PTEN/Akt/mTOR and Ras/Raf/MEK/ERK pathways are the major signaling pathways emerging from the GFRs, including PDGFR. Decreased sensitivity to radiation-induced cell death are often associated with redundancy in these pro-survival signaling pathways. Here we found that Phosphoinositide 3-kinases (PI3K), Extracellular-signal-regulated kinase 1/2 (ERK1/2), or c-Jun N-terminal kinase 1/2 (JNK1/2) inactivation induced radiosensitivity in HGG cells.

Phosphoglycerate Kinase 1 Promotes Radioresistance in U251 Human Glioma Cells.

Phosphoglycerate Kinase 1 Gene Knockdown Suppresses The Migration And Invasion Of Glioma Cells

Cofilin-1 and Phosphoglycerate Kinase-1 Up Regulated the Radiation Resistance in Primary Human Glioma Cells

LRIG 1 Enhances the Radiosensitivity of Radioresistant Human Glioblastoma U 251 Cells Via Attenuation of the EGFR / Akt Signaling Pathway

AKT2-knockdown Suppressed Viability with Enhanced Apoptosis, and Attenuated Chemoresistance to Temozolomide of Human Glioblastoma Cells in Vitro and in Vivo.

Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52

Over-Expression of Cofilin-1 and Phosphoglycerate Kinase 1 in Astrocytomas Involved in Pathogenesis of Radioresistance

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5

Phosphoglycerate Dehydrogenase Induces Glioma Cells Proliferation and Invasion by Stabilizing Forkhead Box M1.

PGK1 Contributes to Tumorigenesis and Sorafenib Resistance of Renal Clear Cell Carcinoma Via Activating CXCR4/ERK Signaling Pathway and Accelerating Glycolysis

Silencing Platelet-Derived Growth Factor Receptor-Β Enhances the Radiosensitivity of C6 Glioma Cells in Vitro and in Vivo.

PGK1-mediated cancer progression and drug resistance

The Diagnostic Value and Functional Roles of Phosphoglycerate Mutase 1 in Glioma.

Upregulation of LGMNP1 Confers Radiotherapy Resistance in Glioblastoma.

Targeting SGK1 Enhances the Efficacy of Radiotherapy in Locally Advanced Rectal Cancer.

UAP1L1 plays an oncogene-like role in glioma through promoting proliferation and inhibiting apoptosis

Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines

The Oncogenic Role and Regulatory Mechanism of PGK1 in Human Non-Small Cell Lung Cancer

Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo.

MicroRNA-17-5p and MicroRNA-130b-3p Promote Radioresistance of Glioma Stem Cells by Targeting PTEN/AKT/HIF-1α Pathway-Controlled Phosphopentose Metabolism

Knockdown of the DNA-dependent Protein Kinase Catalytic Subunit Radiosensitizes Glioma-Initiating Cells by Inducing Autophagy.